Urinary Dopamine Levels Can Predict the Avidity of Post-Therapy [<sup>131</sup>I]MIBG Scintigraphy in Unresectable or Metastatic Pheochromocytomas and Paragangliomas: A Preliminary Clinical Study
<b>Background/Objectives</b>: Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors that produce catecholamines. Unresectable or metastatic PPGLs are treated with [<sup>131</sup>I]metaiodobenzylguanidine (MIBG), but MIBG avidity is often heterogeneous. I...
Saved in:
| Main Authors: | Junki Takenaka, Shiro Watanabe, Takashige Abe, Satoshi Takeuchi, Kenji Hirata, Rina Kimura, Hiroshi Ishii, Naoto Wakabayashi, Mungunkhuyag Majigsuren, Kohsuke Kudo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/2/165 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Biochemical–Imaging Connection: Urinary Noradrenaline and Fluorodeoxyglucose-Positron Emission Tomography in Unresectable or Metastatic Pheochromocytomas and Paragangliomas
by: Junki Takenaka, et al.
Published: (2025-05-01) -
Diagnostic Efficacy of <sup>123</sup>Iodo-Metaiodobenzylguanidine SPECT/CT in Cardiac vs. Neurological Diseases: A Comparative Study of Arrhythmogenic Right Ventricular Cardiomyopathy and α-Synucleinopathies
by: Johannes M. Hagen, et al.
Published: (2024-12-01) -
<sup>131</sup>I-mIBG Therapy in the Management of High-Risk Neuroblastoma: A Retrospective Study from a Tertiary Level Hospital in South India
by: A.R. Vishnu, et al.
Published: (2025-02-01) -
The Vital Role of 131I-MIBG in Localization of Paraganglioma at Unusual Sites
by: Tejasvini Singhal, et al.
Published: (2022-09-01) -
Sex differences in management and outcomes in pheochromocytomas and paragangliomas
by: Måns A. J. Dahl, et al.
Published: (2025-06-01)